CELG

Celgene Corporation Press Releases

$131.25
*  
0.63
0.48%
Get CELG Alerts
*Delayed - data as of Jul. 31, 2015  -  Find a broker to begin trading CELG now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By

Celgene Corporation Commences Tender Offer for Receptos, Inc.
7/28/2015 7:30:00 AM - Business Wire
▼-1.13 % Price Change since this news event. The Volume Ratio is 1.21.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Celgene Reports Second Quarter 2015 Operating and Financial Results
7/23/2015 7:30:00 AM - Business Wire
▼-5.91 % Price Change since this news event. The Volume Ratio is 1.21.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day




Harwood Feffer LLP Announces Investigation of Receptos, Inc.
7/15/2015 3:31:00 PM - PR Newswire
▲0.18 % Price Change since this news event. The Volume Ratio is 4.08.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


RECEPTOS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout
7/15/2015 1:45:00 PM - PR Newswire
▼-1.04 % Price Change since this news event. The Volume Ratio is 4.09.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day




Celgene to Acquire Receptos, Advancing Leadership in Immune-Inflammatory Diseases
7/14/2015 4:58:00 PM - Business Wire
▲5.93 % Price Change since this news event. The Volume Ratio is 7.56.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Celgene Corporation to Announce Second Quarter 2015 Results on July 23, 2015
7/6/2015 8:30:00 AM - Business Wire
▲11.81 % Price Change since this news event. The Volume Ratio is 0.99.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Celgene and Juno Announce Ten-Year Collaboration to Advance Potentially Groundbreaking Immunotherapies for Patients with Cancer and Autoimmune Diseases
6/29/2015 4:05:00 PM - Business Wire
▲14.05 % Price Change since this news event. The Volume Ratio is 1.91.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day




Celgene Announces Additional $4 Billion Share Repurchase Authorization
6/17/2015 7:30:00 AM - Business Wire
▲16.72 % Price Change since this news event. The Volume Ratio is 1.28.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Results from Analyses of Revlimid® MCL-002 (SPRINT) Study Presented at EHA
6/13/2015 9:30:00 AM - Business Wire
▲17.92 % Price Change since this news event. The Volume Ratio is 0.78.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Updated Results from MM-020/IFM 07-01 (First) Study of REVLIMID® Presented at European Hematology Annual Congress
6/12/2015 7:30:00 AM - Business Wire
▲16.18 % Price Change since this news event. The Volume Ratio is 0.74.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Oral Presentation Evaluating Pooled Data on OTEZLA® (apremilast) for Long-Term Improvements in Enthesitis and Dactylitis to Be Presented at EULAR
6/9/2015 6:01:00 PM - Business Wire
▲17.21 % Price Change since this news event. The Volume Ratio is 0.88.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day






Celgene Announces New Data to be Presented at European League Against Rheumatism Annual Congress
6/3/2015 7:30:00 AM - Business Wire
▲15.21 % Price Change since this news event. The Volume Ratio is 1.48.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Celgene Corporation to Webcast at Upcoming Investor Conferences in June
5/28/2015 8:30:00 AM - Business Wire
▲13.10 % Price Change since this news event. The Volume Ratio is 1.23.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day




Analysis of Phase II Data for Celgene’s Investigational Oral GED-0301 in Patients with Active Crohn’s Disease Presented at Digestive Disease Week
5/19/2015 8:15:00 AM - Business Wire
▲12.42 % Price Change since this news event. The Volume Ratio is 0.88.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


FDA Fast Track Designation Granted to Luspatercept for the Treatment of Patients with Beta-Thalassemia
5/18/2015 7:30:00 AM - Business Wire
▲13.93 % Price Change since this news event. The Volume Ratio is 1.01.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Celgene Announces Presentations of Investigational Studies in Solid Tumor and Blood Cancers at ASCO 2015
5/13/2015 5:18:00 PM - Business Wire
▲16.19 % Price Change since this news event. The Volume Ratio is 0.7.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day